We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) (HGNC Symbol)
Entrez gene summary
This gene encodes the protein elongin C, which is a subunit of the transcription factor B (SIII) complex. The SIII complex is composed of elongins A/A2, B and C. It activates elongation by RNA polymerase II by suppressing transient pausing of the polymerase at many sites within transcription units. Elongin A functions as the transcriptionally active component of the SIII complex, whereas elongins B and C are regulatory subunits. Elongin A2 is specifically expressed in the testis, and capable of forming a stable complex with elongins B and C. The von Hippel-Lindau tumor suppressor protein binds to elongins B and C, and thereby inhibits transcription elongation. Multiple alternatively spliced transcript variants encoding two distinct isoforms have been identified. [provided by RefSeq, Mar 2011]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Q15369 [Direct mapping] Transcription elongation factor B polypeptide 1
Show all
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]
Predicted intracellular proteins Plasma proteins Cancer-related genes Mutated cancer genes Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0004842 [ubiquitin-protein transferase activity] GO:0005515 [protein binding] GO:0005654 [nucleoplasm] GO:0005829 [cytosol] GO:0006357 [regulation of transcription from RNA polymerase II promoter] GO:0006366 [transcription from RNA polymerase II promoter] GO:0006368 [transcription elongation from RNA polymerase II promoter] GO:0006511 [ubiquitin-dependent protein catabolic process] GO:0010467 [gene expression] GO:0016032 [viral process] GO:0032968 [positive regulation of transcription elongation from RNA polymerase II promoter] GO:0042787 [protein ubiquitination involved in ubiquitin-dependent protein catabolic process] GO:0050434 [positive regulation of viral transcription] GO:0061418 [regulation of transcription from RNA polymerase II promoter in response to hypoxia] GO:0070449 [elongin complex] GO:0071456 [cellular response to hypoxia]